<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>16423961</Do_id>
  <Journal>AJR. American journal of roentgenology</Journal>
  <Doc_title>MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.</Doc_title>
  <Doc_abstract>Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate.;Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.</Doc_abstract>
  <Doc_ChemicalList>Benzamides;Contrast Media;Piperazines;Protein Kinase Inhibitors;Pyrimidines;Imatinib Mesylate;Iopamidol</Doc_ChemicalList>
  <Doc_meshdescriptors>Aged;Aged, 80 and over;Benzamides;Contrast Media;Female;Gastrointestinal Stromal Tumors;Humans;Image Processing, Computer-Assisted;Imatinib Mesylate;Iopamidol;Male;Middle Aged;Piperazines;Protein Kinase Inhibitors;Pyrimidines;Tomography, X-Ray Computed;Treatment Outcome</Doc_meshdescriptors>
  <Doc_meshqualifiers>diagnostic imaging;drug therapy;therapeutic use;therapeutic use;therapeutic use</Doc_meshqualifiers>
</Document>
